Corvus Pharmaceuticals Inc buy Oppenheimer Holdings Inc.
Start price
20.03.24
/
50%
€1.67
Target price
20.03.25
€6.45
Performance (%)
175.45%
Price
30.09.24
€4.55
Summary
This prediction is currently active. The BUY prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc has seen massive gains of 175.45%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corvus Pharmaceuticals Inc | -5.895% | -5.895% |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.65
07.05.24
07.05.24
€7.42
07.05.25
07.05.25
175.76%
30.09.24
30.09.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.81
17.08.23
17.08.23
-
17.08.24
17.08.24
96.41%
18.08.24
18.08.24